A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With Advanced Solid Tumors

NCT02561234 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Cancers

Interventions

DRUG: Co-ArgI-PEG

Sponsor

Aeglea Biotherapeutics